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Edited by Judit Ova´diAbstract The chirality of the luciferin substrate is critical to the
luciferin–luciferase reaction producing bioluminescence. In ﬁre-
ﬂy, the biosynthetic pathway of D-luciferin is still unclear,
although it can be synthesized in vitro from D-cysteine. Here,
we show that the ﬁreﬂy produces both D- and L-luciferin, and
that the amount of active D-luciferin increases gradually with
maturation stage. Studies of ﬁreﬂy body extracts indicate the
possible conversion of L-cysteine via L-luciferin into D-luciferin,
suggesting that the biosynthesis is enzymatically regulated by
stereoisomeric bio-inversion of L-luciferin. We conclude that
the selection of chirality in living organisms is not as rigid as pre-
viously thought.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Biologically active natural products are usually homochiral:
proteins are composed of mainly L-amino acids and L-menthol
produces a mint-like smell whereas D-menthol is a stronger
stimulant than its L-counterpart. Thus, the determination
and selection of chirality in natural products is considered as
a rigid system.
Bioluminescence is a typical example of a substrate-enzyme
reaction [1]. Most such reactions are eﬃcient and most lucifer-
ins are chiral and are biosynthesized from peptides or L-amino
acid. For instance, only Cypridina L-luciferin exhibits biolumi-
nescence potential although in chemiluminescence, the D-, L-,
and DL-forms produce light of the same intensity [2]. These re-
sults indicate that Cypridina luciferase recognizes only one of
the enantiomers and this luciferin is biosynthesized from L-
amino acids or tripeptides. Similarly, only ﬁreﬂy D-luciferin
contributes to bioluminescence, whereas L-luciferin does not
but strongly inhibits [3,4]. How does ﬁreﬂy biosynthesize D-
luciferin?Abbreviations: ABD-F, 4-(aminosulfonyl)-7-ﬂuoro-2,1,3-benzoxadiaz-
ole; BSA, Bovine serum albumin; CHBT, 2-cyano-6-hydroxybenzo-
thiazole; CoA, coenzyme A; TBP, tri-n-butylphosphine
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doi:10.1016/j.febslet.2006.08.073Fireﬂy D-luciferin can be chemically synthesized from 2-cya-
no-6-hydroxybenzothiazole (CHBT) and D-cysteine [5] whose
stereochemistry corresponds to that of D-luciferin (Fig. 1A).
The putative biosynthetic precursors of D-luciferin are also
cysteine and CHBT [6]. Incorporations of isotope-labeled
DL-cystine and CHBT into D-luciferin in ﬁreﬂies have been re-
ported [7–9]. However, the detail biosynthetic mechanism of
ﬁreﬂy D-luciferin has remained ambiguous for almost half a
century since the ﬁrst report of its chemical structure [5]. Espe-
cially, CHBT is so active that even in the absence of enzyme, it
can react non-enzymatically with L- as well as D-cysteine, pro-
ducing L-luciferin [6]. Although some D-amino acids were re-
ported to have functional roles and to be widely distributed
in living organisms [10], there are no reports to date of the
presence of free D-cysteine and no biosynthetic studies of it
in any eukaryotes [11]. From these ﬁndings, we supposed that
L-luciferin could be the biosynthetic intermediate despite the
fact that it is the enantiomer of a biologically active natural
product (Fig. 1B). On the other hand, Lembert and we have
previously reported the in vitro enzymatic formation of D-
luciferin from L-luciferin [4,12].
In this study, we propose a new biosynthetic pathway of ﬁre-
ﬂy D-luciferin, focussing on its chirality, which has remained
ambiguous since its chemical structure was ﬁrst reported 45
years ago. We show that the ﬁreﬂy contains a considerable
amount of L-luciferin, an enantiomer of active D-luciferin,
and that the enantiomer is enzymatically inverted to D-lucif-
erin. Furthermore, the chirality of cysteine, the putative bio-
synthetic precursor of D-luciferin, is almost L-form. As we
have already reported, luciferase could be responsible for
the stereoisomeric inversion of L-luciferin to D-luciferin [12].
These facts suggest that ﬁreﬂy D-luciferin is synthesized
in vivo from L-cysteine and the biosynthetic intermediate is
L-luciferin.2. Materials and methods
2.1. Materials
The Japanese ﬁreﬂy Luciola lateralis (Coleoptera) was raised in our
laboratory with a commercially available incubation system (Environ-
mental Engineering Laboratory Co., Ltd., Maebashi, Japan). Authen-
tic D- and L-luciferin were prepared from CHBT as previously
described [13].
2.2. Preparation and chiral analysis of ﬁreﬂy luciferin
Twelve larvae, three larvae in cocoon, twelve pupae, six adults in co-
coon, and eight adults of L. lateralis were analyzed as described below.
Luciferin in a ﬁreﬂy body was eluted with 200 ll of ethanol containing
0.5% tri-n-butylphosphine (TBP) at 70 C, and homogenized. Theblished by Elsevier B.V. All rights reserved.
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Fig. 1. Synthesis of ﬁreﬂy D-luciferin. (A) Chemical synthesis of D-luciferin. The asymmetric carbon of cysteine corresponds to that of luciferin. (B)
Hypothetical biosynthetic pathways of D-luciferin from L-cysteine.
5284 K. Niwa et al. / FEBS Letters 580 (2006) 5283–5287sample was centrifuged (13000 rpm, 20 min) and ﬁltered with 0.45 lm
membrane ﬁlter. The ﬁltrate was injected into a high-performance
liquid chromatography (HPLC) system (Alliance HPLC System with
2695 Separation Module, 2475 Multi k Fluorescence Detector, and
2996 Photodiode Array Detector, Waters). Linear gradient elution
(15–40% acetonitrile/water with 0.1% TFA, 20 min, 1.0 ml/min) was
adopted for the separation with a chiral fused silica column, CHIRAL-
CEL OD-RH (4.6 · 150 mm; Daicel Chemical Industry, Tokyo,
Japan). D- and L-Luciferin were detected with a ﬂuorescence detector
(excitation k = 330 nm, emission k = 530 nm, see Fig. 2A).Retention time (min)
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Fig. 2. Chiral analyses of in vivo luciferin and cysteine. (A)
Chromatogram of luciferin in an adult ﬁreﬂy, obtained with a chiral
column. (B) Chromatogram of ABD-labeled cysteine from four adult
ﬁreﬂies, obtained with a chiral column.2.3. Preparation and chiral analysis of ﬁreﬂy cysteine
To extract cysteine, four adult ﬁreﬂy bodies suspended in 400 ll of
1 N HCl and 10 ll of 10% TBP/acetonitrile were homogenized and
incubated at 100 C for 5 min. The sample was centrifuged
(13000 rpm, 20 min) and ﬁltered with 0.45 lm membrane ﬁlter. Cys-
teine from 100 ll of the ﬁltrate was puriﬁed with an ODS column
(OD-SR-5, Daicel), and dried. To label ﬂuorescence, the cysteine frac-
tion was dissolved in 125 ll of 0.1 M sodium borate buﬀer (pH 8.0)
containing 1 mM EDTA, 50 ll of 1.0 mM 4-(aminosulfonyl)-7-ﬂu-
oro-2,1,3-benzoxadiazole (ABD-F, from Dojindo Laboratories,
Kumamoto, Japan) in borate buﬀer, and 5 ll of 10% TBP/acetonitrile.
The mixture was kept at 50 C for 5 min, and then placed on ice and
mixed with 60 ll of 0.1 N HCl. The ﬂuorescence-labeled cysteine was
injected into the HPLC system equipped with a chiral crown ether
fused column, CROWNPAK CR (+) (4.6 · 150 mm; Daicel Chemical
Industry, Tokyo, Japan). Isocratic elution with 0.1% TFA in water
(1.2 ml/min) was adopted for the separation. Fluorescence-labeled
D- and L-cysteine were detected with a ﬂuorescence detector (excitation
k = 380 nm, emission k = 530 nm, see Fig. 2B, upper chart).
2.4. Stereoisomeric inversion assay of ﬁreﬂy extract
To extract proteins, the light organ of an adult ﬁreﬂy was homoge-
nized in 200 ll of 0.1 M Tris–HCl buﬀer (pH 8.0) containing 0.1 M
NaCl, and this was followed by centrifugation (13000 rpm, 20 min)
to remove debris. The extract was dialyzed to remove contamination
by small molecules. An aliquot (200 ll) of 0.1 mM L-luciferin, 1 mM
coenzyme A (CoA), 3 mM ATP, and 8 mM MgSO4 in 0.1 M Tris–
HCl buﬀer (pH 8.0) was mixed with 40 ll of the dialyzed protein
extract and incubated at room temperature. Luciferin chirality was
analyzed with the same procedure as that described above, except that
the eluent was changed to isocratic 27% acetonitrile/water containing
0.1% TFA (Fig. 4A). To test the enzymatic reaction, an aliquot
(2 ll) of 1 mM L-luciferin was mixed with 40 ll of various protein solu-
tions and 198 ll of various cofactor solutions (Fig. 4C). Protein
extracts from Luciola cruciata (sampled from Tsushima Island, Naga-
saki) and Photinus pyralis (from Sigma) were also tested.3. Results and discussion
In order to gain an insight into the biosynthesis of active
luciferin, we analyzed bioluminescence-related compounds
during the life cycle of L. lateralis (Fig. 3). The adult of this
ﬁreﬂy produces ﬂashing light signals to communicate and at-
tract a mate [14]. On the other hand, the larva and pupa occa-
sionally produce a continuous dim glow, the biological
function of which is not known. The larva, an aquatic glow-
worm, feeds on snails but the other stages do not eat anything.
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Fig. 3. Life stage, luciferin content, and D-luciferin chirality. Illustrated are the ﬁve distinctive life stages of the Japanese ﬁreﬂy, L. lateralis. L, larva;
LC, larva in cocoon; P, pupa; AC, adult in cocoon; A, adult. Graphs show the total amounts of D- and L-luciferin in an individual body and the
enantiomeric excess of D-luciferin (% ee). Error bars indicate standard deviations.
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from larva through pupa to adult. We raised the ﬁreﬂy in our
laboratory and collected them to analyze their luciferin by
HPLC with a chiral column. Individual samples were divided
into ﬁve groups depending on the morphologically distinctive
life stages: larva, larva in cocoon, pupa, adult in cocoon, and
adult. As shown in Fig. 3, the more mature the ﬁreﬂy was,
the higher the total amount of luciferin was, demonstrating
that the ﬁreﬂy produces and stores luciferin during pupa and
adult in cocoon stages despite the fasting period. Both L-
and D-luciferin were identiﬁed by their retention times
(Fig. 2A) and biological activities [15]. Both luciferins were
detectable at all stages and the enantiomeric excess of D-lucif-
erin was highest at the adult stage, while it was relatively low
during larval to pupal stages and variable as individual diﬀer-
ences (Fig. 3). Both luciferins were detected in the egg,
although its amount and ratio could not be determined accu-
rately (data not shown). We previously reported that L-lucif-
erin is a substrate for the non-luminous enzymatic reaction
with ﬁreﬂy luciferase in vitro [12,15] and Lembert have previ-
ously reported the light production from L-luciferin [4]. But
these facts could not prove the presence and biological role
of L-luciferin in vivo. Now we proved the existence of L-lucif-
erin in vivo and the change in ratio of D- and L-luciferin with
development, implying that L-luciferin is the biosynthetic inter-
mediate.
As regards to the hypothetical biosynthetic precursor for
luciferin, we analyzed the chirality of cysteine in vivo
(Fig. 2B, lower chart). Although our in vitro assay system en-
abled detection of D- or L-cysteine in amounts as low as 1010
moles (data not shown), faint peaks around the retention time
for D-cysteine were recognized only when the extracts from
four individuals of living ﬁreﬂies were combined. This result
could prove the extreme dominance of L-cysteine over D-cys-
teine. As CHBT readily reacts with both L- and D-cysteine, it
is diﬃcult for the ﬁreﬂy to prevent from producing corre-sponding luciferins, suggesting that L-luciferin in vivo could
be derived from L-cysteine. In vivo, however, L-luciferin must
be inverted to D-luciferin to induce the bioluminescence reac-
tion because inactive L-luciferin strongly inhibits the lucif-
erin–luciferase reaction [4].
The next question is what is responsible for the dispropor-
tionation of luciferin chirality? We previously reported that
in the presence of ATP, Mg2+ and CoA, ﬁreﬂy luciferase exhib-
its coenzyme A ligase (CoA-ligase) activity on L-luciferin
in vitro, but not on D-luciferin, to give luciferyl-CoA [15].
Modiﬁcation of the carboxyl group in L-luciferin accelerates
enolization to give racemic luciferyl-CoA. Hydrolysis of race-
mic luciferyl-CoA could yield both L- and D-luciferin. We re-
cently reported that L-luciferin was stereoisomerically bio-
inverted to produce D-luciferin under enzymatic conditions
in vitro [12].
We examined the enzymatic activity for the stereoisomeric
inversion of L-luciferin in L. lateralis extract (Fig. 4). Soluble
proteins extracted from the light organ and dialyzed with buf-
fer to remove small molecules exhibited inversion activity on
authentic L-luciferin in the presence of ATP, Mg2+, and CoA
(Fig. 4A and B). This activity was suppressed when the extract
was boiled and could not be substituted by known proteins
including bovine serum albumin (BSA), indicating that the ste-
reoisomeric inversion is an enzymatic reaction in the ﬁreﬂy
bioluminescence system (Fig. 4C). The activity was also sup-
pressed in the absence of ATP, Mg2+, or CoA (Fig. 4C), sug-
gesting that the CoA ligation of L-luciferin is essential for the
bio-inversion reaction and luciferyl-CoA could be the interme-
diate. Therefore, CoA-thioesterase could catalyze the hydroly-
sis of D-luciferyl-CoA to yield D-luciferin. Furthermore, the
same potential to invert L-luciferin to D-luciferin was found
in the protein extracts from another Japanese ﬁreﬂy, L. cruci-
ata, as well as a North American ﬁreﬂy, P. pyralis (data not
shown), suggesting that the inversion activity could be ubiqui-
tous among luminous beetles.
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Fig. 4. Stereoisomeric inversion of L-luciferin to D-luciferin in L. lateralis extract. (A) Chromatograms of a reaction mixture containing L-luciferin,
the protein extract, ATP, Mg2+, and CoA. Dashed and solid lines indicate the reaction mixture incubated for 2 and 15 min, respectively. (B) Time
course of the inversion reaction. Ratios of D- and L-luciferin to the initial amount of total luciferin are plotted. (C) Inversion activities under various
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propose a new pathway for D-luciferin biosynthesis, as shown
in Fig. 5. The most important process is the stereoisomeric bio-
inversion at the ﬁnal steps. Luciferase could be responsible for
stereoselective CoA ligation of L-luciferin as well as biolumi-L-luciferin
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metabolism of ibuprofen, in which stereoselective CoA ligation
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the bioluminescent substrate, D-luciferin.
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despite being under bioluminescence reaction conditions was
because the bioluminescence reaction rate was so low [15] that
the consumption of D-luciferin could not be detected in our
reaction conditions.
Lembert [4] ﬁrst reported the light production from L-lucif-
erin and proposed that L-luciferin was racemized to give
D-luciferin and it was eﬀectively stimulated by the addition
of pyrophosphate. This racemization is an in vitro reaction
of luciferase in the absence of CoA. In the presence of CoA,
L-luciferin is readily converted into luciferyl-CoA [15]. Lucifer-
ase in vivo is localized in peroxisome where metabolisms in-
volved in CoA mainly take place [17,18]. Furthermore,
biosynthetic pathway should produce homochiral D-luciferin.
Therefore, we consider our proposal is reasonable as an
in vivo reaction.
Because the ﬁreﬂy is able to invert L-luciferin to D-luciferin
eﬃciently, as shown in Fig. 4B, it is not necessary for the ﬁreﬂy
to produce D-cysteine. Although there remains the possibility,
the ﬁreﬂy does not have to keep mechanisms that CHBT selec-
tively reacts with minimal amounts of D-cysteine to produce
D-luciferin alone.
On the other hand, in the luciferin recycling pathway [19],
the luciferin regeneration enzyme produces CHBT, although
the de novo biosynthesis of CHBT as well as any benzothiazole
compounds in vivo is not clear.
Recently, reports of the multiple functions of luciferase have
emerged: CoA-ligase activity on fatty acids [20], and adenosine
polyphosphate synthetase activity on ATP, ADP, and AMP
[21]. Our results strongly suggest that luciferase also partici-
pates in the biosynthesis of D-luciferin by producing luciferyl-
CoA from L-luciferin. However, further research is required
to elucidate the detailed mechanism after luciferyl-CoA forma-
tion. In previous research, the amount of L-luciferin in vivo and
the existence of enzymes for the inversion of L-luciferin to
D-luciferin have not been considered. This report introduces a
new aspect of the ﬁreﬂy luciferase system.
What is the meaning of disproportionation of luciferin chi-
rality depending on the developmental stage? The ﬂashing light
of the adult L. lateralis is highly regulated whereas the contin-
uous dim glow before metamorphosis is not passively regu-
lated. For the adult, the saving of active D-luciferin could be
helpful for ﬂashing light communication. The ﬂexibility of
luciferin chirality could be part of a physiological regulatory
system. According to the lock and key theory of E. Fischer,
substrate chirality is a rigid system. However, studies of intact
organisms indicate that substrate chirality is more ﬂexible than
previously thought. The ﬁreﬂy bioluminescence system is a
good example of chiral diversity and enzymatic ﬂexibility.
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